165. Antzelevitch C: Molecular biology and cellular
mechanisms of Brugada and long QT syndromes in
infants and young children. J Electrocardiol
34(Suppl):177–181, 2001.
166. Li J, Correa AM: Kinetic modulation of HERG
potassium channels by the volatile anesthetic halo-
thane. Anesthesiology 97:921–930, 2002.
167. Davies LA, Hopkins PM, Boyett MR, et al: Effects of
halothane on the transient outward K(+) current in
rat ventricular myocytes. Br J Pharmacol 131:223–
230, 2000.
168. Sirois JE, Lynch C III, Bayliss DA: Convergent and
reciprocal modulation of a leak K
+
current and I(h)
by an inhalational anaesthetic and neurotransmit-
ters in rat brainstem motoneurones. J Physiol
541:717–729, 2002.
169. Chen X, Sirois JE, Lei Q, et al: HCN subunit-specific
and cAMP-modulated effects of anesthetics on neu-
ronal pacemaker currents.J Neurosci 25:5803–5814,
2005.
170. Robinson RB, Siegelbaum SA: Hyperpolarization-
activated cation currents: From molecules to phy-
siological function. Annu Rev Physiol 65:453–480,
2003.
171. Girault JA, Hemmings HC Jr: Cell signaling.
In
Hemmings HC Jr., Hopkins PM (eds): Foundations
of Anesthesia, 2nd Edition. London, Mosby, 2005,
pp 31–50.
172. Rebecchi MJ, Pentyala SN: Anaesthetic actions on
other targets: protein kinase C and guanine nucleo-
tide-binding proteins. Br J Anaesth 89:62–78, 2002.
173. Peterlin Z,IshizawaY,Araneda R,et al: Selective acti-
vation of G-protein–coupled receptors by volatile
anesthetics. Mol Cell Neurosci 30:506–512, 2005.
174. Minami K, Gereau RW, Minami M, et al: Effects of
ethanol and anesthetics on type 1 and 5 metabotro-
pic glutamate receptors expressed in
Xenopus laevis
oocytes. Mol Pharmacol 53:148–156, 1998.
175. Minami K, Minami M, Harris RA: Inhibition of
5-hydroxytryptamine type 2A receptor-induced
currents by n-alcohols and anesthetics. J Pharmacol
Exp Ther 281:1136–1143, 1997.
176. Minami K, Vanderah TW, Minami M, et al: Inhibi-
tory effects of anesthetics and ethanol on muscari-
nic receptors expressed in
Xenopus
oocytes. Eur J
Pharmacol 339:237–244, 1997.
177. Hemmings HC Jr: General anesthetic effects on
protein kinase C. Toxicol Lett 100:89–95, 1998.
178. Hasegawa J, Takekoshi S, Nagata H, et al: Sevoflu-
rane stimulates MAP kinase signal transduction
through the activation of PKC alpha and betaII in
fetal rat cerebral cortex cultured neuron. Acta His-
tochem Cytochem 39:163–172, 2006.
179. Das J, Addona GH, Sandberg WS, et al: Identifica-
tion of a general anesthetic binding site in the dia-
cylglycerol-binding domain of protein kinase
C-delta. J Biol Chem 279:37964–37972, 2004.
180. Shumilla JA, Sweitzer SM, Eger EI 2nd, et al: Inhibi-
tion of spinal protein kinase C-epsilon or -gamma
isozymes does not affect halothane minimum alveo-
lar anesthetic concentration in rats. Anesth Analg
99:82–84, 2004.
181. Sonner JM,Gong D,Li J,et al: Mouse strainmodestly
influences minimum alveolar anesthetic concentra-
tion and convulsivity of inhaled compounds.Anesth
Analg 89:1030–1034, 1999.
182. Snyder GL, Galdi S, Hendrick JP, et al: General anes-
thetics selectively modulate glutamatergic and
dopaminergic signaling via site-specific phos-
phorylation in vivo. Neuropharmacology 53:619–
630, 2007.
183. Hemmings HC Jr, Adamo AI: Effects of halothane
and propofol on purified brain protein kinase C
activation. Anesthesiology 81:147–155, 1994.
184. Marota JJ, Crosby G, Uhl GR: Selective effects of
pentobarbital and halothane on c-fos and jun-B
gene expression in rat brain. Anesthesiology
77:365–371, 1992.
185. Hamaya Y, Takeda T, Dohi S, et al: The effects of
pentobarbital,isoflurane,and propofol on immediate-
early gene expression in the vital organs of the rat.
Anesth Analg 90:1177–1183, 2000.
186. Culley DJ, Yukhananov RY, Xie ZC, et al: Altered
hippocampal gene expression 2 days after general
anesthesia in rats. Eur J Pharmacol 549:71–78,
2006.
187. Fütterer CD, Maurer MH, Schmitt A, et al: Altera-
tions in rat brain proteins after desflurane anesthe-
sia. Anesthesiology 100:302–308, 2004.
188. Nicoll RA, Madison DV: General anesthetics hyper-
polarize neurons in the vertebrate central nervous
system. Science 217:1055–1057, 1982.
189. Southan AP, Wann KT: Inhalation anaesthetics
block accommodation of pyramidal cell discharge
in the rat hippocampus. Br J Anaesth 63:581–586,
1989.
190. Fujiwara N, Higashi H, Nishi S, et al: Changes in
spontaneous firing patterns of rat hippocampal neu-
rones induced by volatile anaesthetics. J Physiol
(Lond) 402:155–175, 1988.
191. Kullmann DM, Martin RL, Redman SJ: Reduction
by general anaesthetics of group Ia excitatory posts-
ynaptic potentials and currents in the cat spinal
cord. J Physiol (Lond) 412:277–296, 1989.
192. MacIver MB, Roth SH: Inhalation anaesthetics
exhibit pathway-specific and differential actions on
hippocampal synaptic responses in vitro. Br J
Anaesth 60:680–691, 1988.
193. Ries CR, Puil E: Ionic mechanism of isoflurane’s
actions on thalamocortical neurons. J Neurophysiol
81:1802–1809, 1999.
194. Semyanov A,Walker MC,Kullmann DM,et al: Toni-
cally active GABA(A) receptors: Modulating gain
and maintaining the tone. Trends Neurosci 27:262–
269, 2004.
195. Bai D, Zhu G, Pennefather P, et al: Distinct functio-
nal and pharmacological properties of tonic and
quantal inhibitory postsynaptic currents mediated
by
g
-aminobutyric acid
A
receptors in hippocampal
neurons. Mol Pharmacol 59:814–824, 2001.
196. Bieda MC,MacIver MB: Major role for tonic GABA
A
conductances in anesthetic suppression of intrinsic
neuronal excitability. J Neurophysiol 92:1658–1667,
2004.
197. Caraiscos VB, Elliott EM, You T, et al: Tonic inhibi-
tion in mouse hippocampal CA1 pyramidal neurons
is mediated by
a
5 subunit-containing gamma-
aminobutyric acid type A receptors. Proc Natl Acad
Sci U S A 101:3662–3667, 2004.
198. Caraiscos VB, Newell JG, You T, et al: Selective
enhancement of tonic GABAergic inhibition in
murine hippocampal neurons by low concentra-
tions of the volatile anesthetic isoflurane. J Neurosci
24:8454–8458, 2004.
199. Cheng VY, Martin LJ, Elliott EM, et al: Alpha5GA-
BA
A
receptors mediate the amnestic but not sedati-
ve-hypnotic effects of the general anesthetic
etomidate. J Neurosci 26:3713–3720, 2006.
200. Berg-Johnsen J,Langmoen IA:The effect of isoflurane
on excitatory synaptic transmission in the rat hippo-
campus. Acta Anaesthesiol Scand 36:350–355, 1992.
201. Kirson ED, Yaari Y, Perouansky M: Presynaptic and
postsynaptic actions of halothane at glutamatergic
synapses in the mouse hippocampus. Br J Pharma-
col 124:1607–1614, 1998.
202. Richards CD, Smaje JC: Anaesthetics depress the
sensitivity of cortical neurones to L-glutamate. Br J
Pharmacol 58:347–357, 1976.
203. Wakamori M, Ikemoto Y, Akaike N: Effects of two
volatile anesthetics and a volatile convulsant on the
excitatory and inhibitory amino acid responses in
dissociated CNS neurons of the rat. J Neurophysiol
66:2014–2021, 1991.
204. Yang J, Zorumski CF: Effects of isoflurane on
N
-me-
thyl-d-aspartate gated ion channels in cultured rat
hippocampal neurons. Ann NY Acad Sci 625:287–
289, 1991.
205. de Sousa SLM, Dickinson R, Lieb WR, et al: Con-
trasting synaptic actions of the inhalational general
anesthetics isoflurane and xenon. Anesthesiology
92:1055–1066, 2000.
206. Dildy-Mayfield JE,Eger EI 2nd,Harris RA:Anesthetics
produce subunit-selective actions on glutamate recep-
tors. J Pharmacol Exp Ther 276:1058–1065, 1996.
207. Minami K, Wick MJ, Stern-Bach Y, et al: Sites of
volatile anesthetic action on kainate (Glutamate
receptor 6) receptors. J Biol Chem 273:8248–8255,
1998.
208. Banks MI, Pearce RA: Dual actions of volatile anes-
thetics on GABA(A) IPSCs: Dissociation of bloc-
king and prolonging effects. Anesthesiology
90:120–134, 1999.
209. Murugaiah KD, Hemmings HC Jr: Effects of intra-
venous general anesthetics on [3H]GABA release
from rat cortical synaptosomes. Anesthesiology
89:919–928, 1998.
210. Nishikawa K,MacIver MB:Agent-selective effects of
volatile anesthetics on GABA(A) receptor-mediated
synaptic inhibition in hippocampal interneurons.
Anesthesiology 94:340–347, 2001.
211. Westphalen RI,Hemmings HC: Selective depression
by general anesthetics of glutamate versus GABA
release from isolated cortical nerve terminals.
J Pharmacol Exp Ther 304:1188–1196, 2003.
212. Westphalen RI, Hemmings HC Jr: Volatile anesthe-
tic effects on glutamate versus GABA release from
isolated rat cortical nerve terminals: basal release.
J Pharmacol Exp Ther 316:208–215, 2006.
213. Nagele P, Mendel JB, PlaczekWJ, et al: Volatile anes-
thetics bind rat synaptic snare proteins. Anesthesio-
logy 103:768–778, 2005.
214. van Swinderen B, Saifee O, Shebester L, et al: A
neomorphic syntaxin mutation blocks volatile-
anesthetic action in
Caenorhabditis elegan
s. Proc
Natl Acad Sci U S A 96:2479–2484, 1999.
215. Pittson S, Himmel AM, MacIver MB: Multiple
synaptic and membrane sites of anesthetic action in
the CA1 region of rat hippocampal slices. BMC
Neurosci 5:52, 2004.
216. Eckenhoff ME, Chan K, Eckenhoff RG: Multiple
specific binding targets for inhaled anesthetics in
the mammalian brain. J Pharmacol Exp Ther
300:172–179, 2002.
217. Pearce RA, Stringer JL, Lothman EW: Effect of vola-
tile anesthetics on synaptic transmission in the rat
hippocampus. Anesthesiology 71:591–598, 1989.
218. Pearce RA: Volatile anaesthetic enhancement of
paired-pulse depression investigated in the rat
hippocampus in vitro. J Physiol 492:823–840,
1996.
219. Malenka RC, Bear MF: LTP and LTD: An emba-
rrassment of riches. Neuron 44:5–21, 2004.
220. Simon W, Hapfelmeier G, Kochs E, et al: Isoflurane
blocks synaptic plasticity in the mouse hippocam-
pus. Anesthesiology 94:1058–1065, 2001.
221. Desmond NL, Colbert CM, Zhang DX, et al:
NMDA receptor antagonists block the induction of
long-term depression in the hippocampal dentate
gyrus of the anesthetized rat. Brain Res 552:93–98,
1991.
222. Maren S, Baudry M, Thompson RF: Differential
effects of ketamine and MK-801 on the induction of
long-term potentiation. Neuroreport 2:239–242,
1991.
223. Jinks SL, Atherley RJ, Dominguez CL, et al: Isoflu-
rane disrupts central pattern generator activity and
coordination in the lamprey isolated spinal cord.
Anesthesiology 103:567–575, 2005.
224. Munglani R,Andrade J,Sapsford DJ,et al:Ameasure
of consciousness and memory during isoflurane
administration: The coherent frequency. Br J
Anaesth 71:633–641, 1993.
225. Traub RD, Spruston N, Soltesz I, et al: Gamma-fre-
quency oscillations: A neuronal population pheno-
menon, regulated by synaptic and intrinsic cellular
processes, and inducing synaptic plasticity. Prog
Neurobiol 55:563–575, 1998.
226. Dickinson R, Awaiz S, Whittington MA, et al: The
effects of general anaesthetics on carbachol-
evoked gamma oscillations in the rat hippocam-
pus in vitro. Neuropharmacology 44:864–872,
2003.
227. Antkowiak B, Hentschke H: Cellular mechanisms of
gamma rhythms in rat neocortical brain slices
probed by the volatile anaesthetic isoflurane. Neu-
rosci Lett 231:87–90, 1997.
Anestésicos inhalatorios: mecanismos de acción
303
10
Sección II
Farmacología y anestesia
© ELSEVIER. Fotocopiar sin autorización es un delito